Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9875189 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus
Condition: Lichen Planus
Intervention: Drug: Apremilast (CC-10004)

Indicates status has not been verified in more than two years